{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:49:50Z","timestamp":1777535390368,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T00:00:00Z","timestamp":1476316800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10067-016-3448-x","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T08:42:45Z","timestamp":1476348165000},"page":"3075-3079","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Elevated levels of serum MRP8\/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease"],"prefix":"10.1007","volume":"35","author":[{"given":"Latika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,13]]},"reference":[{"key":"3448_CR1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/keh595","volume":"44","author":"A Spoorenberg","year":"2005","unstructured":"Spoorenberg A, van Tubergen A, Landew\u00e9 R, Dougados M, van der Linden S, Mielants H et al (2005) Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) 44:789\u2013795","journal-title":"Rheumatology (Oxford)"},{"key":"3448_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrrheum.2013.14","volume":"9","author":"WH Robinson","year":"2013","unstructured":"Robinson WH, Lindstrom TM, Cheung RK, Sokolove J (2013) Mechanistic biomarkers for clinical decision making in rheumatic diseases. Nat Rev Rheumatol 9:267\u2013276","journal-title":"Nat Rev Rheumatol"},{"key":"3448_CR3","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D et al (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382:1705\u20131713","journal-title":"Lancet"},{"key":"3448_CR4","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s10067-015-3117-5","volume":"35","author":"JA Smith","year":"2016","unstructured":"Smith JA (2016) The role of the unfolded protein response in axial spondyloarthritis. Clin Rheumatol 35:1425\u20131431","journal-title":"Clin Rheumatol"},{"key":"3448_CR5","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/art.30593","volume":"63","author":"L Zeng","year":"2011","unstructured":"Zeng L, Lindstrom MJ, Smith JA (2011) Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis Rheum 63:3807\u20133817","journal-title":"Arthritis Rheum"},{"key":"3448_CR6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/JIM.0000000000000095","volume":"62","author":"P Oktayoglu","year":"2014","unstructured":"Oktayoglu P, Bozkurt M, Mete N, Caglayan M, Em S, Nas K (2014) Elevated serum levels of calprotectin (myeloid-related protein 8\/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life. J Investig Med 62:880\u2013884","journal-title":"J Investig Med"},{"key":"3448_CR7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3899\/jrheum.141365","volume":"42","author":"A Shukla","year":"2015","unstructured":"Shukla A, Gaur P, Aggarwal A (2015) Tenascin-C levels, a toll-like receptor 4 ligand, in enthesitis-related arthritis category of juvenile idiopathic arthritis: a cross-sectional and longitudinal study. J Rheumatol 42:891\u2013896","journal-title":"J Rheumatol"},{"key":"3448_CR8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3389\/fimmu.2014.00473","volume":"5","author":"A Liaunardy-Jopeace","year":"2014","unstructured":"Liaunardy-Jopeace A, Gay NJ (2014) Molecular and cellular regulation of toll-like receptor-4 activity induced by lipopolysaccharide ligands. Front Immunol 5:473","journal-title":"Front Immunol"},{"key":"3448_CR9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","volume":"75","author":"H Cypers","year":"2016","unstructured":"Cypers H, Varkas G, Beeckman S, Debusschere K, Vogl T, Roth J et al (2016) Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Ann Rheum Dis 75:1357\u20131362","journal-title":"Ann Rheum Dis"},{"key":"3448_CR10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s13075-014-0413-4","volume":"16","author":"MC Turina","year":"2014","unstructured":"Turina MC, Yeremenko N, Paramarta JE, De Rycke L, Baeten D (2014) Calprotectin (S100A8\/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis. Arthritis Res Ther 16:413","journal-title":"Arthritis Res Ther"},{"key":"3448_CR11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.berh.2010.05.007","volume":"24","author":"M Rudwaleit","year":"2010","unstructured":"Rudwaleit M, Taylor WJ (2010) Classification criteria for psoriatic arthritis and ankylosing spondylitis\/axial spondyloarthritis. Best Pract Res Clin Rheumatol 24:589\u2013604","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3448_CR12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/rheumatology\/ket375","volume":"53","author":"MT Rahman","year":"2014","unstructured":"Rahman MT, Myles A, Gaur P, Misra R, Aggarwal A (2014) TLR4 endogenous ligand MRP8\/14 level in enthesitis-related arthritis and its association with disease activity and TLR4 expression. Rheumatology (Oxford) 53:270\u2013274","journal-title":"Rheumatology (Oxford)"},{"key":"3448_CR13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3899\/jrheum.150998","volume":"43","author":"PS Patro","year":"2016","unstructured":"Patro PS, Singh A, Misra R, Aggarwal A (2016) Myeloid-related protein 8\/14 levels in rheumatoid arthritis: marker of disease activity and response to methotrexate. J Rheumatol 43:731\u2013737","journal-title":"J Rheumatol"},{"key":"3448_CR14","doi-asserted-by":"crossref","first-page":"696415","DOI":"10.1155\/2014\/696415","volume":"2014","author":"C Hansson","year":"2014","unstructured":"Hansson C, Eriksson C, Alenius G-M (2014) S-calprotectin (S100A8\/S100A9): a potential marker of inflammation in patients with psoriatic arthritis. J Immunol Res 2014:696415","journal-title":"J Immunol Res"},{"key":"3448_CR15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/art.21914","volume":"54","author":"E Kruithof","year":"2006","unstructured":"Kruithof E, De Rycke L, Vandooren B, De Keyser F, FitzGerald O, McInnes I et al (2006) Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis. Arthritis Rheum 54:1795\u20131804","journal-title":"Arthritis Rheum"},{"key":"3448_CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/00365521.2011.648953","volume":"47","author":"E Klingberg","year":"2012","unstructured":"Klingberg E, Carlsten H, Hilme E, Hedberg M, Forsblad-d\u2019Elia H (2012) Calprotectin in ankylosing spondylitis\u2014frequently elevated in feces, but normal in serum. Scand J Gastroenterol 47:435\u2013444","journal-title":"Scand J Gastroenterol"},{"key":"3448_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/ard.37.1.33","volume":"37","author":"BJ Dekker-Saeys","year":"1978","unstructured":"Dekker-Saeys BJ, Meuwissen SG, Van Den Berg-Loonen EM, De Haas WH, Agenant D, Tytgat GN (1978) Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis 37:33\u201335","journal-title":"Ann Rheum Dis"},{"key":"3448_CR18","first-page":"71","volume":"16","author":"A Duran","year":"2016","unstructured":"Duran A, Kobak S, Sen N, Aktakka S, Atabay T, Orman M (2016) Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis. Bosn J Basic Med Sci 16:71\u201374","journal-title":"Bosn J Basic Med Sci"},{"key":"3448_CR19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2009.111187","volume":"69","author":"SJ Pedersen","year":"2010","unstructured":"Pedersen SJ, S\u00f8rensen IJ, Hermann K-GA, Madsen OR, Tvede N, Hansen MS et al (2010) Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 69:1065\u20131071","journal-title":"Ann Rheum Dis"},{"key":"3448_CR20","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811\u20131818","journal-title":"Ann Rheum Dis"},{"key":"3448_CR21","first-page":"961","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al (1999) A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. J Rheumatol 26:961\u2013965","journal-title":"J Rheumatol"},{"key":"3448_CR22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/annrheumdis-2013-204055","volume":"74","author":"S Ramiro","year":"2015","unstructured":"Ramiro S, Stolwijk C, van Tubergen A, van der Heijde D, Dougados M, van den Bosch F et al (2015) Evolution of radiographic damage in ankylosing spondylitis: a 12\u00a0year prospective follow-up of the OASIS study. Ann Rheum Dis 74:52\u201359","journal-title":"Ann Rheum Dis"},{"key":"3448_CR23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/ard.2006.066415","volume":"66","author":"X Baraliakos","year":"2007","unstructured":"Baraliakos X, Listing J, Rudwaleit M, Haibel H, Brandt J, Sieper J et al (2007) Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 66:910\u2013915","journal-title":"Ann Rheum Dis"},{"key":"3448_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2013-203923","volume":"74","author":"IY Choi","year":"2015","unstructured":"Choi IY, Gerlag DM, Herenius MJ, Thurlings RM, Wijbrandts CA, Foell D et al (2015) MRP8\/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Ann Rheum Dis 74:499\u2013505","journal-title":"Ann Rheum Dis"},{"key":"3448_CR25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gut.45.3.362","volume":"45","author":"J Tibble","year":"1999","unstructured":"Tibble J, Sigthorsson G, Foster R, Scott D, Fagerhol M, Roseth A et al (1999) High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 45:362\u2013366","journal-title":"Gut"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3448-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:01:27Z","timestamp":1498352487000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3448-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,13]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3448"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3448-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,13]]}}}